Verwijs Marinus 4
4 · Aerovate Therapeutics, Inc. · Filed May 3, 2024
Insider Transaction Report
Form 4
Verwijs Marinus
Senior Vice President, CMC
Transactions
- Sale
Common Stock
2024-05-02$21.02/sh−1,981$41,631→ 0 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to E*TRADE Securities LLC's Quicksale Trading Plan elected by the reporting person on July 11, 2022.
- [F2]Includes 1,981 shares purchased under the Issuer's 2021 Employee Stock Purchase Plan on April 30, 2024 in a transaction that is exempt under Rule 16b-3(c) and 16b-3(d).
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.972 to $21.12, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.